Encompass Health Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Encompass Health stock has a consensus rating of "Strong Buy" and an average price target of $148.17. The average 1-year stock price forecast is 19.17% higher than the current stock price, while the lowest is $140 (+12.60%) and the highest is $155 (+24.67%).

Price Target: $148.17 (+19.17%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$140	$148.17	$150	$155
Change	+12.60%	+19.17%	+20.65%	+24.67%

Analyst Ratings

The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	12	12	12	12	12	12
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Langston TD Cowen	TD Cowen	Buy Maintains $140	Buy	Maintains	$140	+12.60%	Oct 2, 2026
Andrew Cooper Raymond James	Raymond James	Buy Reiterates $150	Buy	Reiterates	$150	+20.65%	Sep 28, 2026
Pito Chickering Deutsche Bank	Deutsche Bank	Buy Maintains $142	Buy	Maintains	$142	+14.21%	Sep 18, 2026
Matthew Gillmor CFA KeyBanc	KeyBanc	Buy Maintains $147	Buy	Maintains	$147	+18.23%	Sep 17, 2026
Ann Hynes Mizuho Securities	Mizuho Securities	Buy Maintains $140	Buy	Maintains	$140	+12.60%	Aug 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.46B

from 5.94B

8.84%

from 5.94B

Revenue Next Year

6.99B

from 6.46B

8.26%

from 6.46B

EPS This Year

6.11

from 5.45

12.14%

from 5.45

EPS Next Year

6.68

from 6.11

9.27%

from 6.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.01B	4.35B	4.80B	5.37B	5.94B	6.46B
Revenue Growth	12.58%	8.31%	10.41%	11.91%	10.46%	8.84%
Gross Profit	1.70B	1.75B	1.98B	2.23B	2.56B	2.71B
Gross Margin	42.43%	40.32%	41.30%	41.56%	43.22%	41.90%
Operating Income	659.40M	630.20M	731.80M	874.90M	1.05B	1.05B
Net Income	412.20M	271.00M	352.00M	455.70M	566.20M	632.27M
EPS	-	-	-	-	5.45	6.11
EPS Growth	-	-	-	-	23.02%	12.14%
Forward PE	14.99	18.95	18.12	20.09	18.91	20.34
Dividend / Share	1.12	0.86	0.60	0.64	0.72	0.79
Dividend Growth	-	-23.21%	-30.23%	6.67%	12.50%	10.18%
Free Cash Flow	-	-	-	-	439.20M	485.50M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	6.5B
Avg	6.5B
Low	6.4B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	9.1%
Avg	8.8%
Low	8.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	6.19
Avg	6.11
Low	5.84

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	13.5%
Avg	12.1%
Low	7.2%